These ASX 200 shares could rise 25% to 60%

Brokers are tipping these shares to deliver outsized returns for investors.

| More on:
A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are hunting for big returns for your investment portfolio, then look no further than the ASX 200 shares in this article.

That's because analysts are tipping them to rise by 25%+ over the next 12 months. Here's what you need to know about them:

Flight Centre Travel Group Ltd (ASX: FLT)

The team at Macquarie thinks that this travel agent giant is a cheap ASX 200 share to buy right now.

While it wasn't blown away with its full year results in FY 2025, it believes its valuation is attractive and expects improvements in macro conditions to drive strong performances from its key segments. It said:

Outperform. While profit disappointed, both segments delivered solid TTV growth which should accelerate if macro conditions are more supportive. Valuation is attractive, and we see material upside to the current share price over a 12m view.

Macquarie has an outperform rating and $16.55 price target on Flight Centre's shares. Based on its current share price of $13.03, this implies potential upside of 27% for investors over the next 12 months.

In addition, it is forecasting a fully franked dividend yield of 3% in FY 2026, which boosts the total potential return to 30%.

Telix Pharmaceuticals Ltd (ASX: TLX)

Analysts at Bell Potter think that big returns could be coming for patient investors with this beaten down radiopharmaceuticals company's shares.

Although it concedes that this year has been tough for approvals (most recently the denial of Zircaix by the US FDA), it remains very positive on its longer term outlook and appears to see the recent share price weakness as a buying opportunity. It said:

The previous forecast included modest revenues from Zircaix in FY26 ($31m) which is now stripped out and EBITDA is reduced by $13m. The company does not plan to curtail any R&D spend at this point as it remains well capitalised and we expect will continue to generate cash from operations. This is the second CRL for TLX this calendar year. The delay to revenues and knock on effect to the cost of capital (risk) and valuation are material, accordingly our TP is reduced.

Bell Potter has put a buy rating and $23.00 price target on the ASX 200 share. Based on its current share price of $14.60, this suggests that upside of almost 60% is possible for investors between now and this time next year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Flight Centre Travel Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker looking at the share price.
Broker Notes

Broker ratings on 6 ASX shares about to join the ASX 200

These 6 companies will enter the ASX 200 in the December quarter rebalance. Should you buy them?

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

3 reasons this ASX 300 tech stock is forecast to leap 83% in 2026

A leading broker expects some outsized returns from this ASX 300 tech share. Let’s see why.

Read more »

gold share price represented by speeding golden bullet
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 233%

A leading broker expects outsized gains from this ASX All Ords gold stock. But not without risk.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

3 buy-rated ASX 300 shares at 52-week lows

They've fallen far over the past 12 months but have buy ratings from the experts.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in December

These are best buys according to the broker. Here's what it is saying about them.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 30% to 40% in 2026

Looking for big returns? Analysts think these shares could beat the market.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

Analysts name 3 ASX shares to buy this week

Analysts have good things to say about these shares.

Read more »